X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (11) 11
female (7) 7
expression (6) 6
male (6) 6
middle aged (6) 6
adult (5) 5
aged (5) 5
antibodies, monoclonal - immunology (5) 5
immunology (5) 5
immunotherapy (5) 5
oncology (5) 5
antibodies, monoclonal - therapeutic use (4) 4
cancer (4) 4
dendritic cells (4) 4
abridged index medicus (3) 3
activation (3) 3
animals (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - immunology (3) 3
antineoplastic agents - therapeutic use (3) 3
ctla-4 antigen - immunology (3) 3
expansion (3) 3
ipilimumab (3) 3
lymphocytes (3) 3
melanoma (3) 3
melanoma - drug therapy (3) 3
mice (3) 3
squamous cell carcinoma (3) 3
t cells (3) 3
aged, 80 and over (2) 2
alleles (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized - pharmacology (2) 2
antigen (2) 2
antineoplastic agents - adverse effects (2) 2
autoimmunity (2) 2
binding (2) 2
binding epitope (2) 2
cancer vaccines - immunology (2) 2
carcinoma, squamous cell - immunology (2) 2
care and treatment (2) 2
cd137 (2) 2
cell line, tumor (2) 2
cell proliferation (2) 2
cells, cultured (2) 2
cetuximab (2) 2
co-signaling (2) 2
colitis, ulcerative - immunology (2) 2
colitis, ulcerative - pathology (2) 2
crohn disease - pathology (2) 2
crohns-disease (2) 2
dermatology (2) 2
disease (2) 2
endocrine system - drug effects (2) 2
epitopes - immunology (2) 2
foxp3 (2) 2
gastroenterology & hepatology (2) 2
gastrointestinal agents - pharmacology (2) 2
gastrointestinal tract - drug effects (2) 2
genetic aspects (2) 2
glycosylation (2) 2
head and neck neoplasms - immunology (2) 2
hematology (2) 2
immune-responses (2) 2
immunohistochemistry (2) 2
in-vivo (2) 2
inflammatory bowel disease (2) 2
inflammatory-bowel-disease (2) 2
kidney - drug effects (2) 2
killer cells, natural - immunology (2) 2
killer cells, natural - metabolism (2) 2
liver - drug effects (2) 2
lung-cancer (2) 2
lymphocyte activation (2) 2
medical colleges (2) 2
medicine (2) 2
melanoma - pathology (2) 2
models, animal (2) 2
monoclonal antibody (2) 2
monoclonal-antibody (2) 2
neoplasm metastasis (2) 2
nervous system - drug effects (2) 2
non-human primate (2) 2
pancreas - drug effects (2) 2
rapamycin (2) 2
receptors, lymphocyte homing - immunology (2) 2
regulatory t cells (2) 2
research (2) 2
respiratory system - drug effects (2) 2
retrospective studies (2) 2
scchn (2) 2
skin - drug effects (2) 2
skin neoplasms - drug therapy (2) 2
social and behavioral sciences (2) 2
t-lymphocytes, cytotoxic - immunology (2) 2
t-lymphocytes, regulatory - immunology (2) 2
therapy (2) 2
tumor necrosis factor receptor superfamily, member 9 - immunology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53745
Journal Article
PloS one, 2013, Volume 8, Issue 1, p. e53745
Journal Article
Journal Article
Head & Neck, ISSN 1043-3074, 12/2012, Volume 34, Issue 12, pp. 1734 - 1746
Background We performed a pilot study using Trojan vaccines in patients with advanced squamous cell carcinoma of the head and neck (SCCHN). These vaccines are... 
SCCHN | vaccine | HLA‐II | HLA‐I | immune response | HLA-II | HLA-I | SURGERY | LONG PEPTIDES | ALLELES | IDENTIFICATION | CTL EPITOPES | OTORHINOLARYNGOLOGY | IN-VIVO | SQUAMOUS-CELL CARCINOMA | ESTABLISHED MELANOMA | MEMORY T-CELLS | CANCER VACCINES | LYMPHOCYTES | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Neoplasm Proteins - immunology | Male | Human papillomavirus 16 - immunology | Epitopes - immunology | Cancer Vaccines - therapeutic use | Squamous Cell Carcinoma of Head and Neck | Polymerase Chain Reaction | Papillomavirus Infections - immunology | Adult | Female | Virus Activation | T-Lymphocytes, Cytotoxic - immunology | Immunotherapy, Adoptive - methods | Papillomavirus Infections - complications | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Cancer Vaccines - administration & dosage | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Epitopes, T-Lymphocyte | Carcinoma, Squamous Cell - immunology | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Pilot Projects | Interferon-gamma - immunology | Aged | Care and treatment | Squamous cell carcinoma | Peptides | Vaccination | Oncology, Experimental | Melanoma | Research | Cancer vaccines | Surgery, Plastic | Nuclear radiation | Universities and colleges | Macrophage colony stimulating factor | Papillomavirus infections | Public health | Cancer | Antigenic determinants | Medical research | Human papillomavirus | Vaccines | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 7/2009, Volume 58, Issue 7, pp. 997 - 1006
The interaction of Fc fragments of antibodies with the Fcγ receptors is an essential checkpoint in antibody-dependent cellular cytotoxicity (ADCC). Specific... 
Biomedicine | Immunology | SCCHN | Cancer Research | Oncology | Cetuximab | Polymorphisms | ADCC | TARGET-CELLS | MONOCLONAL-ANTIBODY | IMMUNOLOGY | METASTATIC COLORECTAL-CANCER | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | PREDICT RESPONSE | ONCOLOGY | RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | BINDING | EXPRESSION
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 07/2009, Volume 58, Issue 7, p. 997
The interaction of Fc fragments of antibodies with the FcI3 receptors is an essential checkpoint in antibody-dependent cellular cytotoxicity (ADCC). Specific... 
Antimitotic agents | Medical colleges | Squamous cell carcinoma | Epidermal growth factor | Immunoglobulin G | Lymphomas | Genetic aspects | Antineoplastic agents | Health aspects
Journal Article
Current Molecular Medicine, ISSN 1566-5240, 08/2009, Volume 9, Issue 6, pp. 683 - 693
In the vast majority of studies conducted to date, activation of cancer-specific T cell immunity through peptide-based immunization has failed to induce... 
Immunotherapy | Tumor antigen | HLA class I | HLA class II | CTL | Synthetic peptide | T helper cell | Cancer | MEDICINE, RESEARCH & EXPERIMENTAL | COLONY-STIMULATING FACTOR | DENDRITIC CELL | ANTIGEN PRESENTATION | MELANOMA PATIENTS | BREAST-CANCER | tumor antigen | T-CELL RESPONSES | PHASE-I TRIAL | IMMUNE-RESPONSES | immunotherapy | FOREIGN HELPER PROTEIN | synthetic peptide | MHC CLASS-II
Journal Article
Current molecular medicine, 08/2009, Volume 9, Issue 6, p. 683
In the vast majority of studies conducted to date, activation of cancer-specific T cell immunity through peptide-based immunization has failed to induce... 
CD4-Positive T-Lymphocytes - immunology | Epitopes - immunology | Cancer Vaccines - immunology | Humans | Immunotherapy | Clinical Trials as Topic | Vaccines, Subunit - immunology | Vaccines, Synthetic - immunology
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 09/2009, Volume 58, Issue 9, p. 1527
  The online version of the original article can be found under doi: 10.1007/s00262-008-0613-3 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.